Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
- PMID: 28436986
- PMCID: PMC5562020
- DOI: 10.1038/ng.3855
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
Abstract
Complex traits arise from the interplay between genetic and environmental factors. The actions of these factors usually appear to be additive, and few compelling examples of gene-environment synergy have been documented. Here we show that adiposity significantly amplifies the effect of three sequence variants (encoding PNPLA3 p.I148M, TM6SF2 p.E167K, and GCKR p.P446L) associated with nonalcoholic fatty liver disease (NAFLD). Synergy between adiposity and genotype promoted the full spectrum of NAFLD, from steatosis to hepatic inflammation to cirrhosis. We found no evidence of strong interaction between adiposity and sequence variants influencing other adiposity-associated traits. These results indicate that adiposity augments genetic risk of NAFLD at multiple loci that confer susceptibility to hepatic steatosis through diverse metabolic mechanisms.
Conflict of interest statement
None of the authors had potential conflicts of interest.
Figures
Comment in
-
NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD.Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):506-507. doi: 10.1038/nrgastro.2017.74. Epub 2017 Jun 14. Nat Rev Gastroenterol Hepatol. 2017. PMID: 28611479 No abstract available.
-
Thwart your destiny; effect of nonacoholic fatty liver disease genes on steatosis, liver injury and cirrhosis varies by body mass index.Hepatology. 2018 Jul;68(1):372-374. doi: 10.1002/hep.29739. Epub 2018 May 10. Hepatology. 2018. PMID: 29251787 Free PMC article. No abstract available.
References
-
- Cohen JC, et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 2004;305:869–72. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
